Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Silo Wellness Inc C.SILO

Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in psilocybin wellness retreats. It offers psychedelic wellness retreats in Jamaica and is focused on doing the same in Oregon, United States. It also maintains rights in intellectual property (IP). It intends to offer psilocybin retreats in Oregon as well as pursue a clinical psilocybin-assisted counseling element with patients using the psilocybin nasal spray prior to sessions through either licensees or through its own branded psilocybin service centers. The Company's process includes two separate dosing sessions with reflection time between to allow participants a relaxed, natural processing of their experiences. Its subsidiary includes Silo Psychedelics Inc, Advisors LLC., and others.


CSE:SILO - Post by User

Post by GajjarDron Sep 28, 2022 10:55pm
256 Views
Post# 34993938

GOOD NEWS -- $SILO Wellness Acquires Dyscovry Science 📈🤝🏾

GOOD NEWS -- $SILO Wellness Acquires Dyscovry Science 📈🤝🏾THIS UPDATE STRIKES ME BALANCE TO BUY MORE TOMORROW.  "Silo’s patent-pending metered-dosing formulations for psilocybin, DMT, mescaline, and 5-MeO-DMT, and its psychedelic retreat expertise to help unlock the value of its strategic portfolio."

https://www.shorelinebeacon.com/newsfile/138518-silo-wellness-executes-definitive-agreement-to-acquire-dyscovry-science-and-its-psilocybin-pharmaceutical-biosynthesis-and-research-portfolio
<< Previous
Bullboard Posts
Next >>